Leadership During Challenging Times

In a crisis, how do you lead an early-stage company? How do you manage runway and keep morale up, continuing to deliver important work necessary to advance? Two experienced serial entrepreneurs, and the investors who backed them, will get together to share their wisdom. Matt Likens, now CEO of GT Medical, led Ulthera through the 2008 crisis to acquisition six years later. Adam Berman, who now leads Alleviant, launched TVA Medical in 2008 and took it to acquisition in 2018. Justin Klein of Vensana Capital invested in Ulthera under Matt; James Eadie of Santé Ventures invested in TVA under Adam. Join us on Wednesday, June 24 to learn from their past and current experiences.

The New Normal: Understanding a Changing Regulatory Landscape in Response to COVID-19

While new guidelines like social distancing and shelter-in-place affect the average person’s day-to-day experience during the pandemic, temporary changes to coverage and payment rules for health care providers affect theirs. Marc Samuels is Founder & CEO of ADVI Health, a healthcare consulting company that has worked with 19 of the top 25 medtech companies in the world. In this discussion, Marc and ADVI Senior Associate Micaela Laber will explore recent administrative and legislative policy changes in response to the COVID-19 Public Health Emergency and their implications for the present and future of health care. Key topics covered include telehealth, remote monitoring, hospitals without walls, home infusion, and state waivers across Medicare, Medicaid, and commercial payers.

Rosenman D-Series: Small Business Loans Under the CARES Act: What You Need to Know

On March 27, 2020, President Trump signed the Coronavirus Aid, Relief, and Economic Security Act into law, also known as the “CARES Act”. The CARES Act is a wide ranging stimulus bill in response to the COVID-19 outbreak. Title I of the CARES Act (“Keeping American Workers Paid and Employed Act”) provides for the expansion of the Small Business Act (SBA) in order to create a new line of federally-guaranteed small business loans (“Program Loans”) available for the period of February 15, 2020 to June 30, 2020. These Program Loans are available to small businesses with fewer than 500 employees (see below for more detailed information) and permit such qualified small businesses to borrow up to 2.5 times the average total monthly payroll costs incurred in the one-year period before the Program Loan is made with a cap of $10 million. Program Loans do not require any collateral, have a deferred payment period of six months to one year and are eligible for loan forgiveness for certain categories of spending during the eight-week period following the issuance of the loan.
View CARES Act summary

Join us to learn about the CARES Act and find out how your organization can get support. Q&A welcome.

How to Prepare to Sell Your Life Science or Medtech Company

To ensure a successful sale of your startup you need to start planning early. Several issues are key. Among them: how to maximize value; how to manage stakeholders; and how to close the deal, which is everything once you decide to sell. To learn how to do it right—as well as hard-learned lessons about what happens if you don’t—join us on Thursday, February 20 to hear from Sam Williams, a partner in corporate law at the firm Brown Rudnick.